Table 3.
Analysis for the standardized supplemental Functional Assessment of Cancer Therapy (FACT) items
| Estimated difference (99% CI)* | ||
|---|---|---|
| Sexual and vaginal function items | With vs without lymphedema diagnosis | GCLQ total score increment ≥4 vs <4 |
| I am afraid to have sex | −0.19 (−0.52 ~ 0.15) | −0.11 (−0.29 ~ 0.07) |
| My vaginal feels too narrow or short | −0.14 (−0.41 ~ 0.13) | −0.09 (−0.24 ~ 0.07) |
| I am interested in sex | 0.09 (−0.21 ~ 0.38) | −0.05 (−0.26 ~ 0.16) |
| I have hot flashes | −0.09 (−0.39 ~ 0.22) | −0.11 (−0.31 ~ 0.09) |
| I have vaginal bleeding or spotting | −0.02 (−0.12 ~ 0.09) | −0.03 (−0.10 ~ 0.03) |
| I have pain or discomfort with intercourse | −0.18 (−0.49 ~ 0.13) | −0.19 (−0.40 ~ 0.02) |
| I am bothered by pain or numbness in my vulvar | −0.03 (−0.20 ~ 0.14) | −0.12 (−0.25 ~ 0.02) |
| Estimated difference (99% CI)* | ||
| With vs without lymphedema diagnosis | GCLQ total score increment ≥4 vs <4 | |
| I am satisfied with my sexual life (GS7) | −0.33 (−0.80 ~ 0.14) | −0.24 (−0.52 ~ 0.04) |
| Estimated difference (99% CI)* | ||
| Body image Item | With vs without lymphedema diagnosis | GCLQ total score increment ≥4 vs <4 |
| I like the appearance of my body | −0.08 (−0.31 ~ 0.16) | −0.1 (−0.26 ~ 0.06) |
| I feel sexually attractive | −0.06 (−0.16 ~ 0.29) | −0.08 (−0.25 ~ 0.08) |
| I am unhappy about a change in my appearance | −0.4 (−0.64 ~ −0.16) | −0.31 (−0.44 ~ −0.17) |
Differences in sexual and vaginal function item scores were estimated from a fitted linear mixed model adjusting for baseline score, disease sites, and assessment time when patients had a lymphedema diagnosis on the GCLQ or when patients had a GCLQ increment change ≥4.
difference was estimated from a fitted linear mixed model adjusting for baseline score, disease sites, and assessment time when patients had a lymphedema diagnosis on the GCLQ or when patients had a GCLQ increment change ≥4.
differences in body image item scores were estimated from a fitted linear mixed model adjusting for baseline score, disease sites, and assessment time when patients had a lymphedema diagnosis on the GCLQ or when patients had a GCLQ increment change ≥4.
GCLQ, Gynecologic Cancer Lymphedema Questionnaire